Biofrontera AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other
pharmaceutical manufacturers in Europe:
sales of 19.93 million Euro [US$22.09 million]
(181.51 million Norwegian Kroner [US$19.77 million]
of which 61%
was Hexvix/Cysview Own Sales), and
Vistin Pharma ASA
based in Norway
(198.99 million Norwegian Kroner [US$21.67 million]
of which 101%
Biofrontera AG reported sales of 21.11 million Euro (US$23.40 million)
December of 2018.
increase of 75.5%
versus 2017, when the company's sales were 12.03 million Euro.
This was the fourth straight year of sales growth at Biofrontera AG.